Preparing the
Business for
Study Start-up
Change
Jess Robinson
Director, Study Start-up
Agenda
1
2
3
Introduction
Compelling reasons to transform study start-up
People, Process, and Technology
The pillars that drive change
Results
What GSK has achieved with Vault Study Startup
4 Q&A
Get your questions answered
GSK’s Unified Technology Journey
Build the capabilities
of our people
Improve the user experience for all
personnel involved
1
2
Become a more efficient organisation
to support faster timelines
3
6
5
4
Drive standardisation across business
units supporting a global process change
Unified Clinical eco-system with single entry
point, workflows, and complete view
people process technology
Integrated Reporting allows AI and Machine
Learning with improved data quality
Clinical Vault Programme: Collection of current clinical operations projects joined
together to extract maximum value for GSK. Using Tech solutions as the catalyst to align.
people process technologyprocess
Opportunities to Improve Key Processes
• Data and functionality
across disparate systems
• Little visibility to roadblocks
• Process delays due to
inefficient technology
• Mixed model for
accountabilities
• Siloed ways of working
• Six methods + email
• Manual collection
SITE DOCUMENT EXCHANGE REG/ETHICS SUBMISSIONS SITE GREENLIGHT
6
  
Unified solution: align processes to demonstrate value
Process Changes Affected the Rollout Approach
• Documents from Study
Start-up go directly to eTMF
• Integration from Vault to
drug release system
• Consider interactions
between RIM, eTMF, and
Study Startup
• Shared responsibility
across country users
• Manage rollout across
two Vaults/cross-links
• Focus on site
relationships and
experience – become
sponsor of choice
• Tech solutions as
catalyst to align
SITE DOCUMENT EXCHANGE REG/ETHICS SUBMISSIONS SITE GREENLIGHT
7
people process technologytechnology
Balancing the risk of new system implementation and study delivery
Our Phased Approach to Rollout
MEET THE TEAM
• Core team: Business &
Tech
• Designated Ambassadors
• Became SMEs and
helped build the
system
• Train the trainers
• Every country has
POC to handhold
– PHASE I
– (Initially two phases, combined into one)
– 20 countries
• Implemented as many countries as possible to ensure consistency across
studies (most countries use Vault Study Startup)
• Extended country intel period to pressure test
Deployed site document exchange to ready the business
(large-scale change that impacts entire business)
– PHASE II
– 10 countries
SYSTEM GO-LIVE: JULY 2020
INTERIM
PHASE
9
Cross-Vault team assignment and Governance
Vault Study Startup Learnings
10
Designate people who understand the business and impacts across
applications to ensure changes in one system don’t affect another (milestones)
Work with TMF teams to understand milestone configurations
Establish a steering committee who can make decisions that impact both
eTMF and Study Startup
Define a central group who is responsible for all Vaults to eliminate siloed
decision-making and manage access rights
people process technologypeople
Change management tactics
Preparing the Business
12
&
Include end users
from the start
Identify strategic
change champions
Enable agility with the
right team structure
&
GSK’s Unified Study Start-up Journey Results
13
people process technology
• Introduced Global Study
Start-up Team
• Cultural shift: data-driven
decision-making, metrics and
KPIs, strong ambition
• Alignment across business
units for simplification
• Focus on what regulations
are required rather than
tweaking original processes
• Inherently siloed – tech needs
to support, not complicate
• Decisions to meet needs of
end user – simplification and
efficiency
Key Takeaways
14
Account for cross-
Vault implications
when making
decisions
Structure team to
drive alignment and
agile decisions
Start-up tech should
support people and
processes
Dedicate time to
change management
to increase adoption
Q&A

GSK: Preparing the Business for Study Start-up Change

  • 1.
    Preparing the Business for StudyStart-up Change Jess Robinson Director, Study Start-up
  • 2.
    Agenda 1 2 3 Introduction Compelling reasons totransform study start-up People, Process, and Technology The pillars that drive change Results What GSK has achieved with Vault Study Startup 4 Q&A Get your questions answered
  • 4.
    GSK’s Unified TechnologyJourney Build the capabilities of our people Improve the user experience for all personnel involved 1 2 Become a more efficient organisation to support faster timelines 3 6 5 4 Drive standardisation across business units supporting a global process change Unified Clinical eco-system with single entry point, workflows, and complete view people process technology Integrated Reporting allows AI and Machine Learning with improved data quality Clinical Vault Programme: Collection of current clinical operations projects joined together to extract maximum value for GSK. Using Tech solutions as the catalyst to align.
  • 5.
  • 6.
    Opportunities to ImproveKey Processes • Data and functionality across disparate systems • Little visibility to roadblocks • Process delays due to inefficient technology • Mixed model for accountabilities • Siloed ways of working • Six methods + email • Manual collection SITE DOCUMENT EXCHANGE REG/ETHICS SUBMISSIONS SITE GREENLIGHT 6   
  • 7.
    Unified solution: alignprocesses to demonstrate value Process Changes Affected the Rollout Approach • Documents from Study Start-up go directly to eTMF • Integration from Vault to drug release system • Consider interactions between RIM, eTMF, and Study Startup • Shared responsibility across country users • Manage rollout across two Vaults/cross-links • Focus on site relationships and experience – become sponsor of choice • Tech solutions as catalyst to align SITE DOCUMENT EXCHANGE REG/ETHICS SUBMISSIONS SITE GREENLIGHT 7
  • 8.
  • 9.
    Balancing the riskof new system implementation and study delivery Our Phased Approach to Rollout MEET THE TEAM • Core team: Business & Tech • Designated Ambassadors • Became SMEs and helped build the system • Train the trainers • Every country has POC to handhold – PHASE I – (Initially two phases, combined into one) – 20 countries • Implemented as many countries as possible to ensure consistency across studies (most countries use Vault Study Startup) • Extended country intel period to pressure test Deployed site document exchange to ready the business (large-scale change that impacts entire business) – PHASE II – 10 countries SYSTEM GO-LIVE: JULY 2020 INTERIM PHASE 9
  • 10.
    Cross-Vault team assignmentand Governance Vault Study Startup Learnings 10 Designate people who understand the business and impacts across applications to ensure changes in one system don’t affect another (milestones) Work with TMF teams to understand milestone configurations Establish a steering committee who can make decisions that impact both eTMF and Study Startup Define a central group who is responsible for all Vaults to eliminate siloed decision-making and manage access rights
  • 11.
  • 12.
    Change management tactics Preparingthe Business 12 & Include end users from the start Identify strategic change champions Enable agility with the right team structure &
  • 13.
    GSK’s Unified StudyStart-up Journey Results 13 people process technology • Introduced Global Study Start-up Team • Cultural shift: data-driven decision-making, metrics and KPIs, strong ambition • Alignment across business units for simplification • Focus on what regulations are required rather than tweaking original processes • Inherently siloed – tech needs to support, not complicate • Decisions to meet needs of end user – simplification and efficiency
  • 14.
    Key Takeaways 14 Account forcross- Vault implications when making decisions Structure team to drive alignment and agile decisions Start-up tech should support people and processes Dedicate time to change management to increase adoption
  • 15.